As of 2024-12-14, the Fair Value of Transgene SA (TNG.PA) is -0.80 EUR. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.73 EUR, the upside of Transgene SA is -210.42%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -18.80 | -17.23 | -19.54 | -32.80 | -22.33 | -22.14 |
| YoY growth | -334.29% | 8.37% | -13.38% | -67.92% | 31.94% | -75.06% |
| Market Cap (mil) | 96.31 |
| P/E | |
| Forward P/E |
| EPS | -0.16 |
| Avg earnings growth rate | -75.06% |
| TTM earnings | -21.27 |